ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
ATOVAQUONE; PROGUANIL HYDROCHLORIDE
Approval overview ATOVAQUONE AND PROGUANIL HYDROCHLORIDE is listed in Drugs@FDA under application 202362 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ATOVAQUONE; PROGUANIL HYDROCHLORIDE Form and strength TABLET;ORAL - 250MG;100MG Sponsor MYLAN Submission history Latest submission status date: 2019-11-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview ATOVAQUONE AND PROGUANIL HYDROCHLORIDE is listed in Drugs@FDA under application 202362 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ATOVAQUONE; PROGUANIL HYDROCHLORIDE Form and strength TABLET;ORAL - 250MG;100MG Sponsor MYLAN Submission history Latest submission status date: 2019-11-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.